Modified Antibody - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Medical Care > Modified Antibody - Global Top Players Market Share and Ranking 2025

Modified Antibody - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-09-18
Report Id: 2405157
Industry: Medical Care
Report Page: 113
Chart: 120

PDF Download

Publication Date: 2025-09-18
Report Id: 2405157
Industry: Medical Care
Report Page: 113
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Modified Antibody Definition
1.2 Global Modified Antibody Market Size and Forecast
1.2.1 By Consumption Value, Global Modified Antibody Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Modified Antibody Market Size, 2020-2031
1.2.3 Global Modified Antibody Average Selling Price (ASP), 2020-2031
1.3 China Modified Antibody Market Size and Forecast
1.3.1 By Consumption Value, China Modified Antibody Market Size, 2020-2031
1.3.2 By Sales Quantity, China Modified Antibody Market Size, 2020-2031
1.3.3 China Modified Antibody Average Selling Price (ASP), 2020-2031
1.4 Share of China Modified Antibody Market with Respect to the Global Market
1.4.1 By Consumption Value, China Modified Antibody Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Modified Antibody Market Share in Global, 2020-2031
1.4.3 Modified Antibody Market Size: China VS Global, 2020-2031
1.5 Modified Antibody Market Dynamics
1.5.1 Modified Antibody Market Drivers
1.5.2 Modified Antibody Market Restraints
1.5.3 Modified Antibody Industry Trends
1.5.4 Modified Antibody Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Modified Antibody, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Modified Antibody, Global Market Share by Company, 2020-2025
2.3 Modified Antibody Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Modified Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Modified Antibody Concentration Ratio
2.6 Global Modified Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global Modified Antibody Manufacturers Product Type
2.8 Head Office and Modified Antibody Production Site of Key Manufacturer
2.9 Modified Antibody Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Modified Antibody, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Modified Antibody, China Market Share by Company, 2020-2025
3.3 China Modified Antibody Modified Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Modified Antibody Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Modified Antibody Capacity by Region
4.3 Global Modified Antibody Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Modified Antibody Production by Region, 2020-2031
4.5 Global Modified Antibody Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Modified Antibody Industry Chain
5.2 Modified Antibody Upstream Analysis
5.2.1 Modified Antibody Core Raw Materials
5.2.2 Main Manufacturers of Modified Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Modified Antibody Production Mode
5.6 Modified Antibody Procurement Model
5.7 Modified Antibody Industry Sales Model and Sales Channels
5.7.1 Modified Antibody Sales Model
5.7.2 Modified Antibody Typical Distributors

6 Sights by Type
6.1 Modified Antibody Classification by Type
6.1.1 Histone Modification Antibodies
6.1.2 Non-Histone Modification Antibodies
6.2 by Type, Global Modified Antibody Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Modified Antibody Consumption Value, 2020-2031
6.4 by Type, Global Modified Antibody Sales Quantity, 2020-2031
6.5 by Type, Global Modified Antibody Average Selling Price (ASP), 2020-2031

7 Sights by Application
7.1 Modified Antibody Segment by Application
7.1.1 Cancer Treatment
7.1.2 Immunopathy Treatment
7.1.3 Diagnosis
7.1.4 Scientific Research
7.1.5 Others
7.2 by Application, Global Modified Antibody Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Modified Antibody Consumption Value, 2020-2031
7.4 by Application, Global Modified Antibody Sales Quantity, 2020-2031
7.5 by Application, Global Modified Antibody Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Modified Antibody Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Modified Antibody Consumption Value, 2020-2031
8.3 By Region, Global Modified Antibody Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Modified Antibody Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Modified Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe Modified Antibody Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Modified Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Modified Antibody Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Modified Antibody Market Size Market Share
8.7 South America
8.7.1 South America Modified Antibody Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Modified Antibody Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Modified Antibody Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Modified Antibody Consumption Value, 2020-2031
9.3 By Country, Global Modified Antibody Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Modified Antibody Market Size, 2020-2031
9.4.2 by Type, United States Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Modified Antibody Market Size, 2020-2031
9.5.2 by Type, Europe Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Modified Antibody Market Size, 2020-2031
9.6.2 by Type, China Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Modified Antibody Market Size, 2020-2031
9.7.2 by Type, Japan Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Modified Antibody Market Size, 2020-2031
9.8.2 by Type, South Korea Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Modified Antibody Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Modified Antibody Market Size, 2020-2031
9.10.2 by Type, India Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Modified Antibody Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Modified Antibody Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Modified Antibody Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile
10.1 RevMAb Biosciences
10.1.1 RevMAb Biosciences Company Information, Head Office, Market Area, and Industry Position
10.1.2 RevMAb Biosciences Modified Antibody Models, Specifications, and Application
10.1.3 RevMAb Biosciences Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 RevMAb Biosciences Company Profile and Main Business
10.1.5 RevMAb Biosciences Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.2.2 Thermo Fisher Scientific Modified Antibody Models, Specifications, and Application
10.2.3 Thermo Fisher Scientific Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Thermo Fisher Scientific Company Profile and Main Business
10.2.5 Thermo Fisher Scientific Recent Developments
10.3 BioCat GmbH
10.3.1 BioCat GmbH Company Information, Head Office, Market Area, and Industry Position
10.3.2 BioCat GmbH Modified Antibody Models, Specifications, and Application
10.3.3 BioCat GmbH Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 BioCat GmbH Company Profile and Main Business
10.3.5 BioCat GmbH Recent Developments
10.4 Merck
10.4.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merck Modified Antibody Models, Specifications, and Application
10.4.3 Merck Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Merck Company Profile and Main Business
10.4.5 Merck Recent Developments
10.5 ProteoGenix
10.5.1 ProteoGenix Company Information, Head Office, Market Area, and Industry Position
10.5.2 ProteoGenix Modified Antibody Models, Specifications, and Application
10.5.3 ProteoGenix Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 ProteoGenix Company Profile and Main Business
10.5.5 ProteoGenix Recent Developments
10.6 Biorbyt
10.6.1 Biorbyt Company Information, Head Office, Market Area, and Industry Position
10.6.2 Biorbyt Modified Antibody Models, Specifications, and Application
10.6.3 Biorbyt Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Biorbyt Company Profile and Main Business
10.6.5 Biorbyt Recent Developments
10.7 Cusabio
10.7.1 Cusabio Company Information, Head Office, Market Area, and Industry Position
10.7.2 Cusabio Modified Antibody Models, Specifications, and Application
10.7.3 Cusabio Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Cusabio Company Profile and Main Business
10.7.5 Cusabio Recent Developments
10.8 Rockland
10.8.1 Rockland Company Information, Head Office, Market Area, and Industry Position
10.8.2 Rockland Modified Antibody Models, Specifications, and Application
10.8.3 Rockland Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Rockland Company Profile and Main Business
10.8.5 Rockland Recent Developments
10.9 Proteintech
10.9.1 Proteintech Company Information, Head Office, Market Area, and Industry Position
10.9.2 Proteintech Modified Antibody Models, Specifications, and Application
10.9.3 Proteintech Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Proteintech Company Profile and Main Business
10.9.5 Proteintech Recent Developments
10.10 PTM BIO
10.10.1 PTM BIO Company Information, Head Office, Market Area, and Industry Position
10.10.2 PTM BIO Modified Antibody Models, Specifications, and Application
10.10.3 PTM BIO Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 PTM BIO Company Profile and Main Business
10.10.5 PTM BIO Recent Developments
10.11 Elabscience Biotechnology
10.11.1 Elabscience Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.11.2 Elabscience Biotechnology Modified Antibody Models, Specifications, and Application
10.11.3 Elabscience Biotechnology Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Elabscience Biotechnology Company Profile and Main Business
10.11.5 Elabscience Biotechnology Recent Developments
10.12 AtaGenix
10.12.1 AtaGenix Company Information, Head Office, Market Area, and Industry Position
10.12.2 AtaGenix Modified Antibody Models, Specifications, and Application
10.12.3 AtaGenix Modified Antibody Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.12.4 AtaGenix Company Profile and Main Business
10.12.5 AtaGenix Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Modified Antibody should grow from US$ 2977 million in 2024 to US$ 5708 million by 2031, with a CAGR of 8.4% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Modified Antibody

According to YH Research, the global market for Modified Antibody should grow from US$ 2977 million in 2024 to US$ 5708 million by 2031, with a CAGR of 8.4% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

A modified antibody refers to an antibody whose structure or function has been altered through genetic engineering, protein engineering, or chemical modification. The modifications are designed to improve affinity and specificity, extend serum half-life, reduce immunogenicity, or introduce additional functions such as multispecific binding, drug conjugation, or fusion with other functional domains.

Modified antibodies in the research reagent market are typically priced at USD 5–50 per microliter, depending on the modification type, purity, and production scale; for clinical-grade therapeutics, the effective cost per microliter can exceed USD 100.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Modified Antibody market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Modified Antibody market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Cancer Treatment grew percent to account for percent of the total market sales, and Immunopathy Treatment grew percent.

This report studies and analyses global Modified Antibody status and future trends, helps the client to determine the Modified Antibody market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Modified Antibody, and provides market size (in μl & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Modified Antibody market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (μl)
(2) Global Modified Antibody sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (μl)
(3) China Modified Antibody sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (μl)
(4) Global Modified Antibody key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Modified Antibody key producing regions, capacity, production, and year over year growth
(6) Modified Antibody industry chains, upstream, midstream and downstream
Market segment by players, this report covers
RevMAb Biosciences
Thermo Fisher Scientific
BioCat GmbH
Merck
ProteoGenix
Biorbyt
Cusabio
Rockland
Proteintech
PTM BIO
Elabscience Biotechnology
AtaGenix

Market segment by Type, covers
Histone Modification Antibodies
Non-Histone Modification Antibodies

Market segment by Application, can be divided into
Cancer Treatment
Immunopathy Treatment
Diagnosis
Scientific Research
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Modified Antibody product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Modified Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Modified Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Modified Antibody, percent & CAGR, 2020-2031
Chapter 5: Modified Antibody industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.